Conventional / global / constitutive KO
We build the exact model your study needs.
Designed and delivered by ingenious targeting laboratory. Quote in 24 hours.
AI Answer
ingenious targeting laboratory designs knockout, conditional knockout, knockin, humanized, and transgenic models for 700+ priority genes across signaling, immune, cancer, neuroscience, metabolism, and morphogen pathways. Quote in 24 hours. 100% germline transmission guarantee.
Associate your project with the full PI search taxonomy, from knockout through backgrounds.
Specify tissue or Cre driver on quote
Convertible floxed allele pathway
Multi allele / compound knockout project
BAC scale deletion or targeting
LSL or conditional expression knockin
Domain or partial humanization scope
Checkpoint IO humanization when gene is a checkpoint target
Multi humanized / combination IO project
BAC transgenic or large fragment insert
Tamoxifen or dox inducible Cre
Dual recombinase breeding scheme
Flp or FRT derivative allele pairing
Catalog reporter lines not tied to a single gene allele
Specify rat on quote
Specify rabbit on quote
Background substrain on quote
Background strain on quote
Open a gene hub for catalog paths, or request a quote for that mouse symbol.
158 genes in Core signaling and cell cycle
Filter by human symbol, mouse symbol, or alias
Knockout mice carry targeted deletions that eliminate gene function, enabling loss of function studies across every therapeutic area. ingenious targeting laboratory offers multiple knockout strategies for your experimental requirements.
Conventional knockout models carry constitutive null alleles that eliminate gene function in all tissues from the earliest developmental stages. These models provide straightforward interpretation of genes that are not required for embryonic viability.
Learn MoreConditional knockout models use the Cre lox system to enable tissue specific or temporally controlled gene deletion. The floxed allele design preserves normal gene function until Cre recombinase excises a critical region, providing experimental control over when and where knockout occurs.
Learn MoreBy crossing floxed alleles with tissue specific Cre driver lines, researchers can study gene function in specific cell populations while maintaining normal function elsewhere. This approach is essential when conventional knockout causes embryonic lethality or systemic effects that obscure tissue specific phenotypes.
Learn MoreInducible systems such as tamoxifen activated CreERT2 allow temporal control over gene deletion. This enables study of gene function in adult animals and avoids developmental compensation that can mask phenotypes in constitutive models.
Learn MoreKnockout first designs (tm1a / IKMC style) deliver a convertible pathway from a reporter tagged null allele to a conditional floxed allele, supporting flexible study designs from a single targeting event.
Learn MoreMulti allele and compound knockout projects combine two or more targeted loci for pathway redundancy, synthetic lethality, and complex disease modeling on defined backgrounds.
Learn MoreBAC scale deletion and large fragment targeting remove extended genomic regions when conventional exon deletion is not sufficient for your research question.
Learn MoreKnockin mice carry precise sequence insertions at defined genomic locations. Unlike random transgenesis, knockin targeting ensures predictable expression levels and eliminates position effects.
Point mutation models introduce specific nucleotide changes to study disease associated variants, alter protein function, or modify regulatory elements.
Learn MoreReporter knockin models express fluorescent proteins, enzymatic markers, or other reporters under control of endogenous regulatory elements. This enables visualization of gene expression patterns, lineage tracing, and cell isolation based on marker expression.
Learn MoreTag knockin models add epitope tags such as FLAG, HA, or V5 to endogenous proteins. These tags enable protein detection, purification, and interaction studies without requiring gene specific antibodies.
Learn MorecDNA knockin replaces a gene with a coding sequence, often to express modified proteins, isoform variants, or humanized sequences. The targeted approach ensures expression under endogenous regulatory control.
Learn MoreConditional knockin designs such as Rosa26 LSL enable inducible or tissue restricted expression of inserted sequences while preserving baseline physiology until recombination.
Learn MoreGene replacement knockin substitutes mouse coding sequence with a human or engineered ortholog at the endogenous locus for preclinical target fidelity.
Learn MoreHumanized mice carry human gene sequences in place of mouse orthologs, enabling preclinical testing of human specific therapeutics and study of human disease mechanisms.
Complete gene replacement substitutes the entire mouse gene with its human ortholog, including regulatory elements that control expression. This approach preserves physiological expression patterns while providing human target sequences.
Learn MoreHumanized immune checkpoint models express human PD1, PDL1, CTLA4, LAG3, TIM3, or other checkpoint proteins. These models enable testing of checkpoint inhibitor antibodies in immunocompetent mice with functional immune systems.
Learn MoreTherapeutic antibodies often show species specificity that prevents testing in standard mouse models. Humanizing the target receptor or protein enables preclinical efficacy studies in physiologically relevant contexts.
Learn MoreBacterial artificial chromosome (BAC) targeting enables integration of large genomic segments including complete genes with native regulatory elements. This approach is valuable when physiological expression patterns are essential.
Learn MorePartial or domain humanization replaces selected exons or functional domains when full gene replacement is unnecessary, reducing project scope while preserving key human epitopes or binding sites.
Learn MoreDouble and multi humanized projects combine two or more humanized loci for combination IO, receptor pairs, or multi target therapeutic programs on a single defined background.
Learn MoreRandom and safe harbor transgenesis, overexpression alleles, BAC inserts, and Cre driver lines complete the PI search taxonomy for model generation beyond targeted knockout and knockin.
Random integration and overexpression transgenic models for rapid gain of function studies, with project design guidance on copy number and founder screening.
Learn MoreTargeted insertion at Rosa26, H11, and related safe harbor loci for predictable expression without disrupting essential genes.
Learn MoreConstitutive and inducible Cre driver lines for tissue specific or temporal control of floxed alleles across conditional knockout and knockin programs.
Learn MoreRequest a quote for BAC transgenic, overexpression, or dual recombinase breeding schemes tailored to your allele plan.
Learn MoreEvery mouse model generation project begins with scientific consultation. Our team reviews your research goals, evaluates targeting strategy options, and recommends the approach most likely to deliver the experimental capabilities you need.
Every project includes detailed documentation of targeting design, germline transmission records, and genotyping protocols. This documentation supports ongoing research and future breeding programs.
“We are actively engaged in the production of a number of conditional mouse models with iTL. This collaboration has been simple on my end, just providing the gene accession numbers of each gene, and iTL recommending the strategies for each gene. The full range of mouse knockout services matches my needs well. I find iTL's service uniquely useful for my situation of needing different models for my research in a quick and efficient manner.”
— Mehboob Hussain, MD
University of Michigan Health
Mouse model generation from ingenious targeting laboratory have contributed to over 800 peer reviewed publications.
Newsletter
Subscribe to Lab Signals for biweekly guides on mouse model design, targeting strategies, and research best practices from our PhD scientists.